Skip Navigation


JAC Advance Access originally published online on November 12, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/6/1005    most recent
dkg488v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kahlmeter, G.
Right arrow Articles by Cars, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahlmeter, G.
Right arrow Articles by Cars, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 52, 1005-1010
© 2003 The British Society for Antimicrobial Chemotherapy

Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection

G. Kahlmeter1,*, P. Menday2 and O. Cars3

1 Department of Clinical Microbiology, Central Hospital, SE-351 85 Växjö; 3 Swedish Institute for Infectious Disease Control, Stockholm, Sweden; 2 LEO Pharma, Ballerup, Denmark

Received 2 June 2003; returned 17 August 2003; revised 24 September 2003; accepted 27 September 2003

Objectives: To investigate the correlation between non-hospital antimicrobial consumption and resistance.

Methods: Information on the non-hospital sales of antimicrobials from 14 European countries in 1997 and 2000 was compared with the antimicrobial resistance profiles of Escherichia coli isolated from women with community-acquired urinary tract infection in the same countries in 1999/2000.

Results: There was no statistically significant correlation between the consumption of and resistance to co-amoxiclav, cefadroxil, fosfomycin, mecillinam, sulfamethoxazole, trimethoprim or trimethoprim–sulfamethoxazole. On the other hand, there were statistically significant correlations between consumption of broad-spectrum penicillins and quinolones in 1997 and 2000 and resistance to ciprofloxacin (P range 0.0005–0.0045) and nalidixic acid (P range 0.0013–0.0049). Total antimicrobial consumption in 1997 was significantly correlated to ciprofloxacin (P = 0.0009) and nalidixic acid (P = 0.0018) resistance, and there were significant relationships between quinolone consumption in both years and resistance to gentamicin (P range 0.0029–0.0043) and nitrofurantoin (P range 0.0003–0.0007). E. coli with multiple antimicrobial resistance were significantly more common in countries with high total antimicrobial consumption.

Conclusions: Owing to the frequent presence of many possible confounding factors, antimicrobial resistance to one drug does not always correlate well to the consumption of the same drug or closely related drugs. This study showed that the degree of antimicrobial consumption was significantly correlated to the incidence of multidrug-resistant E. coli.

Keywords: ß-lactams, quinolones, multiple resistance, Europe

* Corresponding author. Tel: +46-470-587477; Fax: +46-470-587455; E-mail: gunnar.kahlmeter{at}ltkronoberg.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
P. Karpanoja, S. T. Nyberg, M. Bergman, T. Voipio, P. Paakkari, P. Huovinen, H. Sarkkinen, and and the Finnish Study Group for Antimicrobial Resi
Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2480 - 2485.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Arslan, O. K. Azap, O. Ergonul, F. Timurkaynak, and on behalf of the Urinary Tract Infection Study Gro
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey
J. Antimicrob. Chemother., November 1, 2005; 56(5): 914 - 918.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. J. Drews, S. M. Poutanen, T. Mazzulli, A. J. McGeer, A. Sarabia, S. Pong-Porter, Y. Rzayev, B. Willey, K. Green, and D. E. Low
Decreased Prevalence of Virulence Factors among Ciprofloxacin-Resistant Uropathogenic Escherichia coli Isolates
J. Clin. Microbiol., August 1, 2005; 43(8): 4218 - 4220.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. D. Hay, M. Thomas, A. Montgomery, M. Wetherell, A. Lovering, C. McNulty, D. Lewis, B. Carron, E. Henderson, and A. MacGowan
The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data
J. Antimicrob. Chemother., July 1, 2005; 56(1): 146 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Landgren, H. Oden, I. Kuhn, A. Osterlund, and G. Kahlmeter
Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries
J. Antimicrob. Chemother., June 1, 2005; 55(6): 928 - 937.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.